Epidemiology of primary hepatic malignancies in U.S. children

Abstract

The epidemiology of primary hepatic malignancies in U.S. children is poorly characterized. We analyzed the incidence, mortality, and characteristics of primary hepatic malignancies in U.S. residents less than 20 years of age. Fatal primary hepatic malignancies in persons less than 20 years of age, between 1979 and 1996, were identified using the multiple-cause-ofdeath database (National Center for Health Statistics). Histologically confirmed primary hepatic malignancies occurring between 1973 and 1997 were identified using the Surveillance, Epidemiology, and End Results (SEER) database. Between 1979 and 1996, 918 primary hepatic malignancy deaths (average, 0.7/1,000,000/year) were reported nationally among persons less than 20 years of age; rates were higher among Asians and among foreignborn children. Between 1973 and 1997, 271 primary hepatic malignancy cases were reported to SEER among persons less than 20 years of age, of which 184 (67%) and 83 (31%) were hepatoblastoma and hepatocellular carcinoma, respectively. Among children less than 5 years of age, hepatoblastoma accounted for 91% of primary hepatic malignancy cases, whereas among those 15 to 19 years of age, hepatocellular carcinoma accounted for 87% of cases. Five-year survival for hepatoblastoma was 52%, compared with 18% for hepatocellular carcinoma. In the SEER sites, between 1973 and 1977 and 1993 and 1997, hepatoblastoma rates increased (0.6 to 1.2/1,000,000, respectively), while hepatocellular carcinoma rates decreased (0.45 to 0.29/1,000,000, respectively). In conclusion, histologically confirmed hepatocellular carcinoma was reported in children less than 5 years of age, also, where hepatoblastoma is the predominant primary hepatic malignancy. Hepatocellular carcinoma has worse survival rates than hepatoblastoma, and its incidence has not increased. Better maintenance of databases may provide information about associated factors behind this unexpected occurrence. (HEPATOLOGY 2003;38:560-566.) P rimary hepatic malignancies are rare in children. 1

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium

“…The majority of pediatric liver tumors are sporadic, but they can also be associated with familial cancer syndromes, metabolic disorders and predisposing conditions, such as extreme prematurity and low birth weight. 1,2 The rarity of these tumors, even in specialized institutions, makes their diagnoses challenging for the general pathologist, particularly because of the lack of a current international consensus classification. Furthermore, it is difficult, even for a national group of investigators, to assemble enough patients to undertake controlled therapeutic trials and large biological studies.…”

A Single Center Experience of Management of Hepatocellular Carcinoma in Children and Adolescents

“…Pediatric primary liver tumors are a rare disease, accounting for about 1% (0.5%-2%) of all childhood cancers [1]. Hepatocellular carcinoma (HCC) constitutes 25%-30% of primary malignant liver tumors in children, and is the 2nd most common malignant hepatic tumor after hepatoblastoma [2,3].…”

“…is about 30%-40%. In fact, 60%-70% of childhood HCC, develops within a normal liver [1][2][3][4][5].…”

Pediatric hepatoblastoma and hepatocellular carcinoma: lessons learned in the last decade

“…This is especially important when dealing with diseases that have an incidence of~1-1.5 in a million [5]. Standardized, high-quality imaging and interpretation is essential in therapeutic studies to ensure accuracy of outcomes data.…”